JP2008517907A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008517907A5 JP2008517907A5 JP2007537852A JP2007537852A JP2008517907A5 JP 2008517907 A5 JP2008517907 A5 JP 2008517907A5 JP 2007537852 A JP2007537852 A JP 2007537852A JP 2007537852 A JP2007537852 A JP 2007537852A JP 2008517907 A5 JP2008517907 A5 JP 2008517907A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- alkoxy
- phenyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 28
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 25
- 125000003545 alkoxy group Chemical group 0.000 claims 20
- 125000001589 carboacyl group Chemical group 0.000 claims 18
- 125000004414 alkyl thio group Chemical group 0.000 claims 17
- 229910052736 halogen Inorganic materials 0.000 claims 17
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 16
- 150000002367 halogens Chemical class 0.000 claims 16
- 125000001424 substituent group Chemical group 0.000 claims 15
- 125000000753 cycloalkyl group Chemical group 0.000 claims 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 125000005843 halogen group Chemical group 0.000 claims 8
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 7
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 7
- 229910052799 carbon Inorganic materials 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 125000005605 benzo group Chemical group 0.000 claims 4
- 229920006395 saturated elastomer Polymers 0.000 claims 4
- 208000036110 Neuroinflammatory disease Diseases 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 150000003583 thiosemicarbazides Chemical class 0.000 claims 3
- 125000006564 (C4-C8) cycloalkyl group Chemical group 0.000 claims 2
- DSIJDUJKTCEJJV-UHFFFAOYSA-N 4-(1-benzylpyrrolidin-3-yl)-3-(pyridin-2-ylmethyl)-1h-1,2,4-triazole-5-thione Chemical compound C1CN(CC=2C=CC=CC=2)CC1N1C(=S)NN=C1CC1=CC=CC=N1 DSIJDUJKTCEJJV-UHFFFAOYSA-N 0.000 claims 2
- DHACMRCOUZAXIW-UHFFFAOYSA-N 4-(5-bicyclo[2.2.1]hept-2-enyl)-3-(pyridin-2-ylmethyl)-1h-1,2,4-triazole-5-thione Chemical compound C1C(C=C2)CC2C1N1C(=S)NN=C1CC1=CC=CC=N1 DHACMRCOUZAXIW-UHFFFAOYSA-N 0.000 claims 2
- VWTGWQVEZNTOOW-QZTJIDSGSA-N 4-[(1r,2r)-2-phenylmethoxycyclopentyl]-3-(pyridin-2-ylmethyl)-1h-1,2,4-triazole-5-thione Chemical compound N1([C@H]2[C@@H](CCC2)OCC=2C=CC=CC=2)C(=S)NN=C1CC1=CC=CC=N1 VWTGWQVEZNTOOW-QZTJIDSGSA-N 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 150000001602 bicycloalkyls Chemical group 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- LZTSCEYDCZBRCJ-UHFFFAOYSA-N 1,2-dihydro-1,2,4-triazol-3-one Chemical compound OC=1N=CNN=1 LZTSCEYDCZBRCJ-UHFFFAOYSA-N 0.000 claims 1
- PKNRQMXMRFEVOF-UHFFFAOYSA-N 3-(phenoxymethyl)-4-(1,2,3,4-tetrahydronaphthalen-1-yl)-1h-1,2,4-triazole-5-thione Chemical compound C1CCC2=CC=CC=C2C1N1C(=S)NN=C1COC1=CC=CC=C1 PKNRQMXMRFEVOF-UHFFFAOYSA-N 0.000 claims 1
- FLBQIMSOGDTURS-VXGBXAGGSA-N 3-[(2-chlorophenoxy)methyl]-4-[(1r,2r)-2-hydroxycyclohexyl]-1h-1,2,4-triazole-5-thione Chemical compound O[C@@H]1CCCC[C@H]1N1C(=S)NN=C1COC1=CC=CC=C1Cl FLBQIMSOGDTURS-VXGBXAGGSA-N 0.000 claims 1
- LACBLGBBENACJR-UHFFFAOYSA-N 3-[3-(phenoxymethyl)-5-sulfanylidene-1h-1,2,4-triazol-4-yl]oxolan-2-one Chemical compound O=C1OCCC1N1C(=S)NN=C1COC1=CC=CC=C1 LACBLGBBENACJR-UHFFFAOYSA-N 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 150000001263 acyl chlorides Chemical class 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 239000007822 coupling agent Substances 0.000 claims 1
- 125000005022 dithioester group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 239000012948 isocyanate Substances 0.000 claims 1
- 150000002513 isocyanates Chemical class 0.000 claims 1
- 150000002540 isothiocyanates Chemical class 0.000 claims 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- -1 ring system halogen Chemical class 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0402591A SE0402591D0 (sv) | 2004-10-25 | 2004-10-25 | Novel use |
| PCT/SE2005/001593 WO2006046910A1 (en) | 2004-10-25 | 2005-10-24 | Novel use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008517907A JP2008517907A (ja) | 2008-05-29 |
| JP2008517907A5 true JP2008517907A5 (enExample) | 2008-11-06 |
Family
ID=33448711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007537852A Pending JP2008517907A (ja) | 2004-10-25 | 2005-10-24 | 新規な使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080096929A1 (enExample) |
| EP (1) | EP1807404A1 (enExample) |
| JP (1) | JP2008517907A (enExample) |
| CN (1) | CN101048392A (enExample) |
| SE (1) | SE0402591D0 (enExample) |
| WO (1) | WO2006046910A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR039385A1 (es) | 2002-04-19 | 2005-02-16 | Astrazeneca Ab | Derivados de tioxantina como inhibidores de la mieloperoxidasa |
| MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| TW200804383A (en) | 2006-06-05 | 2008-01-16 | Astrazeneca Ab | New compounds |
| KR20110089868A (ko) * | 2008-12-12 | 2011-08-09 | 아스트라제네카 아베 | ４-［４-메틸-５-(ｃ1-10알킬티오／ｃ5-10아릴-ｃ1-6알킬티오)-４ｈ-１,２,４-트리아졸-3-일］피리딘을 제조하기 위한 신규 방법 |
| EP2366431A1 (en) | 2010-03-19 | 2011-09-21 | Universitätsklinikum Hamburg-Eppendorf | Myeloperoxidase as a target in atrial fibrillation |
| CA2853024C (en) | 2011-11-11 | 2017-08-22 | Pfizer Inc. | 2-thiopyrimidinones |
| JP2018515480A (ja) | 2015-05-05 | 2018-06-14 | ファイザー・インク | ２−チオピリミジノン |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3135753A (en) * | 1961-05-10 | 1964-06-02 | Burroughs Wellcome Co | Alkylthiopurines and method |
| US4710503A (en) * | 1985-02-07 | 1987-12-01 | Euroceltique S.A. | 6-thioxanthine derivatives |
| US5100906A (en) * | 1990-04-19 | 1992-03-31 | Merrell Dow Pharmaceuticals Inc. | 5-aryl-4-alkyl-3h-1,2,4-triazole-3-thiones useful as memory enhancers |
| FR2665636B1 (fr) * | 1990-08-10 | 1994-10-07 | Adir | Utilisation d'un derive de la trimethyl-1,3,7 xanthine pour le traitement des troubles de la memoire, des troubles intellectuels de la senescence et de la maladie d'alzheimer. |
| US6046019A (en) * | 1991-07-09 | 2000-04-04 | Goumeniouk; Alexander P. | Diagnostic kits and methods for making granulocyte cell counts |
| WO1995014681A1 (en) * | 1993-11-26 | 1995-06-01 | Pfizer Inc. | Isoxazoline compounds as antiinflammatory agents |
| US5489598A (en) * | 1994-06-08 | 1996-02-06 | Warner-Lambert Company | Cytoprotection utilizing aryltriazol-3-thiones |
| US6066641A (en) * | 1994-12-13 | 2000-05-23 | Euro-Celtique S.A. | Aryl thioxanthines |
| US6025361A (en) * | 1994-12-13 | 2000-02-15 | Euro-Celtique, S.A. | Trisubstituted thioxanthines |
| US5756511A (en) * | 1995-04-03 | 1998-05-26 | Cell Therapeutics, Inc. | Method for treating symptoms of a neurodegenerative condition |
| US6294541B1 (en) * | 1996-06-06 | 2001-09-25 | Euro-Celtique S.A. | Purine derivatives having phosphodiesterase IV inhibition activity |
| US5976823A (en) * | 1997-03-19 | 1999-11-02 | Integrated Biomedical Technology, Inc. | Low range total available chlorine test strip |
| US6319928B1 (en) * | 1998-11-30 | 2001-11-20 | Euro-Celtique, S.A. | Purine derivatives having phosphodiesterase IV inhibition activity |
| US6492406B1 (en) * | 1999-05-21 | 2002-12-10 | Astrazeneca Ab | Pharmaceutically active compounds |
| GB2362101A (en) * | 2000-05-12 | 2001-11-14 | Astrazeneca Ab | Treatment of chronic obstructive pulmonary disease |
| FR2819723B1 (fr) * | 2001-01-23 | 2006-11-17 | Arnaud Mainnemare | Composition halogene, son procede de preparation et ses utilisations |
| SE0103766D0 (sv) * | 2001-11-09 | 2001-11-09 | Astrazeneca Ab | Novel assay |
| ES2193839B1 (es) * | 2001-06-22 | 2005-02-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de 6-fenildihidropirrolpirimidindiona. |
| AR039385A1 (es) * | 2002-04-19 | 2005-02-16 | Astrazeneca Ab | Derivados de tioxantina como inhibidores de la mieloperoxidasa |
| SE0301232D0 (sv) * | 2003-04-25 | 2003-04-25 | Astrazeneca Ab | Novel use |
| SE0302756D0 (sv) * | 2003-10-17 | 2003-10-17 | Astrazeneca Ab | Novel Compounds |
-
2004
- 2004-10-25 SE SE0402591A patent/SE0402591D0/xx unknown
-
2005
- 2005-10-24 CN CNA2005800366110A patent/CN101048392A/zh active Pending
- 2005-10-24 WO PCT/SE2005/001593 patent/WO2006046910A1/en not_active Ceased
- 2005-10-24 EP EP05797536A patent/EP1807404A1/en not_active Withdrawn
- 2005-10-24 JP JP2007537852A patent/JP2008517907A/ja active Pending
- 2005-10-24 US US11/577,833 patent/US20080096929A1/en not_active Abandoned